Kalaris Therapeutics (KLRS) Total Liabilities (2019 - 2020)
Kalaris Therapeutics (KLRS) has 2 years of Total Liabilities data on record, last reported at $19.8 million in Q3 2020.
- For Q3 2020, Total Liabilities fell 54.31% year-over-year to $19.8 million; the TTM value through Sep 2020 reached $19.8 million, down 54.31%, while the annual FY2019 figure was $17.8 million, N/A changed from the prior year.
- Total Liabilities reached $19.8 million in Q3 2020 per KLRS's latest filing, up from $16.0 million in the prior quarter.
- Across five years, Total Liabilities topped out at $60.0 million in Q1 2020 and bottomed at $16.0 million in Q2 2020.